REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Dr. Max Pharma S.R.O. (Czech Republic)

Main Activities: Chemical Manufacturing
Full name: Dr. Max Pharma S.R.O. Profile Updated: November 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Dr. Max Pharma S.R.O. is an enterprise located in Czech Republic, with the main office in Prague. It operates in the Chemical Manufacturing industry. The company was established on May 03, 2016. It currently has a total number of 50 - 99 (2023) employees. Dr. Max Pharma S.R.O.’s net profit margin decreased by 0.07% in 2023.

Headquarters
Na Florenci 2116/15
Prague; The City of Prague; Postal Code: 11000

Contact Details: Purchase the Dr. Max Pharma S.R.O. report to view the information.

Website: http://www.drmaxpharma.com

Basic Information
Total Employees:
Purchase the Dr. Max Pharma S.R.O. report to view the information.
Outstanding Shares:
Purchase the Dr. Max Pharma S.R.O. report to view the information.
Registered Capital:
Purchase the Dr. Max Pharma S.R.O. report to view the information.
Financial Auditors:
Purchase the Dr. Max Pharma S.R.O. report to view the information.
Incorporation Date:
May 03, 2016
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Dr. Max Pharma S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Total operating revenue
-22.94%▼
Operating Profit Margin (ROS)
-0.09%▼
Net Profit Margin
-0.07%▼
Return on Equity (ROE)
-0.23%▼
Debt to Equity Ratio
-0.21%▼
Cash Ratio
-100%▼

Similar companies

Orlen Unipetrol Rpa S.R.O.
 
Agrofert, A.S.
Zentiva, K.S.
 
Lovochemie, A.S.
Deza, A.S.
 
Teva Czech Industries S.R.O.
Glenmark Pharmaceuticals S.R.O.
 
Pro.Med.Cs Praha A.S.
Kayaku Safety Systems Europe A.S.
 
Dukol Ostrava, S.R.O.
Boehringer Ingelheim, Spol. S R.O.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo